Dr Sam Whitehouse brings 18 years of experience in Life Science and Pharmaceutical development to LightOx, and will focus initially on the seed investment round in Spring 2018.
LightOx Limited today announced that Dr Sam Whitehouse has taken on the role of Chief Executive Officer, and opened the seed funding round for the expansion of the LightOx product portfolio, and development of new therapeutics.
Dr Whitehouse is an experienced board member with executive experience in Life Science sectors. Sam will oversee the commercialisation of the LightOx products for therapeutic and life science applications.
